Stocks › JNJ
JOHNSON & JOHNSON
JNJ·NYSE·
United States·USD
United States·USD$252.93
-3.10 (-1.21%)
Close · Oct 5, 2026 · Close Prices from Tiingo.com
JNJ
JOHNSON & JOHNSON · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
JNJS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of JNJ by members of U.S. Congress · 488 on record · 35 in the last 12 months
Whale Activity
Position changes in JNJ reported for 2026-09-30 by 46 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased1
- Closed0
- No prior filing45
| Filer | Shares | Value | Change |
|---|---|---|---|
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | 666.7K | $176.5M | — |
| EASTERN BANK | 299.3K | $79.2M | — |
| CACTI ASSET MANAGEMENT LLC | 258.2K | $69.1M | — |
| MassMutual Private Wealth & Trust, FSB | 170.9K | $45.3M | — |
| CapWealth Advisors, LLC | 136.9K | $36.2M | — |
| PARK NATIONAL CORP /OH/ | 121.3K | $32.1M | — |
| Violich Capital Management, Inc. | 83.6K | $22.1M | — |
| ROCKLAND TRUST CO | 74.4K | $19.7M | — |
| ARGENT CAPITAL MANAGEMENT LLC | 69.9K | $18.5M | — |
| Stonebridge Financial Group, LLC | 38.5K | $10.2M | — |
| Eastover Investment Advisors LLC | 36.1K | $9.6M | — |
| Legacy Private Trust Co. | 35.7K | $9.4M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by JNJ insiders, by quarter · Form 4
Recent Insider Transactions
2,031 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Schmid TimothyEVP, WW Chair, MedTech | Sale | −22.5K | $274.74 | $6.2M | Sep 2, 2026 | Form 4 ↗ |
| Schmid TimothyEVP, WW Chair, MedTech | Sale | −11.1K | $274.74 | $3.0M | Sep 2, 2026 | Form 4 ↗ |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Sale | −15.0K | $263.36 | $4.0M | Aug 17, 2026 | Form 4 ↗ |
| Duato JoaquinCEO and Chairman of the Board · Director | Sale | −21.0K | $262.00 | $5.5M | Aug 13, 2026 | Form 4 ↗ |
| Duato JoaquinCEO and Chairman of the Board · Director | Sale | −102.3K | $261.00 | $26.7M | Aug 13, 2026 | Form 4 ↗ |
| Forminard ElizabethEVP, Chief Legal Officer | Sale | −9,344 | $257.75 | $2.4M | Aug 6, 2026 | Form 4 ↗ |
| Forminard ElizabethEVP, Chief Legal Officer | Sale | −6,574 | $255.93 | $1.7M | Aug 6, 2026 | Form 4 ↗ |
| Duato JoaquinCEO and Chairman of the Board · Director | Sale | −6,523 | $258.74 | $1.7M | Aug 5, 2026 | Form 4 ↗ |
| Duato JoaquinCEO and Chairman of the Board · Director | Sale | −42.0K | $258.06 | $10.8M | Aug 5, 2026 | Form 4 ↗ |
| Broadhurst VanessaEVP, Global Corp Affairs | Sale | −23.1K | $251.27 | $5.8M | Jul 20, 2026 | Form 4 ↗ |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Sale | −10.0K | $241.15 | $2.4M | Jun 11, 2026 | Form 4 ↗ |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Option exercise | +10.0K | $115.67 | $1.2M | Jun 11, 2026 | Form 4 ↗ |
| REED JOHN CEVP, Innovative Medicine, R&D | Tax withholding | −11.0K | $229.85 | $2.5M | May 1, 2026 | Form 4 ↗ |
| REED JOHN CEVP, Innovative Medicine, R&D | Option exercise | +25.3K | $0.00 | $0 | May 1, 2026 | Form 4 ↗ |
| Decker Robert JVP Corporate Controller | Sale | −4,075 | $247.87 | $1.0M | Feb 27, 2026 | Form 4 ↗ |
| Decker Robert JVP Corporate Controller | Option exercise | +4,075 | $115.67 | $471K | Feb 27, 2026 | Form 4 ↗ |
| Schmid TimothyEVP, WW Chair, MedTech | Sale | −1,322 | $245.66 | $325K | Feb 20, 2026 | Form 4 ↗ |
| Schmid TimothyEVP, WW Chair, MedTech | Sale | −8,998 | $244.53 | $2.2M | Feb 18, 2026 | Form 4 ↗ |
| Schmid TimothyEVP, WW Chair, MedTech | Option exercise | +8,998 | $129.51 | $1.2M | Feb 18, 2026 | Form 4 ↗ |
| Schmid TimothyEVP, WW Chair, MedTech | Sale | −13.6K | $244.20 | $3.3M | Feb 18, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding JNJ · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 76.4M | $19.41B | 0.84% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 62.4M | $15.84B | 0.95% | Jun 30, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 33.1M | $8.41B | 0.95% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 29.2M | $7.41B | 0.95% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 30.8M | $6.95B | 0.84% | May 31, 2026 |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 22.9M | $5.82B | 2.29% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 17.0M | $4.32B | 10.64% | Jun 30, 2026 |
| VANGUARD DIVIDEND APPRECIATION INDEX FUND VANGUARD SPECIALIZED FUNDS | 13.6M | $3.49B | 2.67% | Jul 31, 2026 |
| VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 13.1M | $3.32B | 0.95% | Jun 30, 2026 |
| VANGUARD HIGH DIVIDEND YIELD INDEX FUND VANGUARD WHITEHALL FUNDS | 9.7M | $2.49B | 2.51% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list JNJ's shares (CUSIP 478160104), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming johnson johnson as client
- FORBES-TATEJOHNSON & JOHNSON · 2026 Q3 · HCR, MMM—
Filing ↗ - HART HEALTH STRATEGIESJOHNSON & JOHNSON SERVICES INC · 2026 Q2—
Filing ↗ - TODD STRATEGY GROUPJOHNSON & JOHNSON SERVICES, INC. · 2026 Q2 · HCR$100K
Filing ↗ - SPLITOAK STRATEGIES LLCJOHNSON & JOHNSON SERVICES, INC. · 2026 Q2 · MMM$50K
Filing ↗ - JOHNSON & JOHNSON SERVICES, INC.JOHNSON & JOHNSON SERVICES INC · 2026 Q2 · DEF, HCR, BUD, CPT$1.4M
Filing ↗
Government Contracts
Federal awards to johnson johnson · USAspending
$1.2MAwarded · 36 contracts on record
- Department of Veterans AffairsINTEGRATED SURGICAL ENERGY PLATFORM SYSTEM$109K
Sep 1, 2026 · ↗ - Department of Defense4571863937!RADIAL HEAD W/ 22MM HD, 8.5MM STM,10(+0)$48K
May 15, 2026 · ↗ - Department of Defense4571246672!2.0MM VOLT SCREWS, 6-50, 1H 1/3W AL$33K
Mar 23, 2026 · ↗ - Department of Defense4571364085!LARGE EX-FIX COMBINATION CLAMP$30K
Apr 2, 2026 · ↗ - Department of Defense4571504448!2.7MM/3.5MM LCP POSTLAT DISTAL$10K
Apr 15, 2026 · ↗ - Department of Defense4571418465!10MM/130 DEG TI CANN TFNA$30K
Apr 8, 2026 · ↗ - Department of Health and Human ServicesEO 14398 - BPA FOR VARIOUS MEDICAL SUPPLIES FOR THE MEDICAL SUPPLY DEPARTMENT$100K
Oct 1, 2026 · ↗ - Department of Defense4571439483!FORCEPS PLATE HOLDING$198K
Apr 10, 2026 · ↗
U.S. Patents
Recent USPTO applications naming JOHNSON & JOHNSON
No USPTO patent applications found for JOHNSON & JOHNSON.
Annual Financials
From JNJ's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $94.19B | $88.82B | $85.16B | $79.99B | $78.74B |
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | $20.88B |
| Diluted EPS | $11.03 | $5.79 | $13.72 | $6.73 | $7.81 |
| Operating cash flow | $24.53B | $24.27B | $22.79B | $21.19B | $23.41B |
| Cash and equivalents | $19.71B | $24.11B | $21.86B | $12.89B | $14.49B |
| Total assets | $199.21B | $180.10B | $167.56B | $187.38B | $182.02B |
| Total liabilities | $117.67B | $108.61B | $98.78B | $110.57B | $108.00B |
As JOHNSON & JOHNSON tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 11, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitJun 13, 2001
- 2-for-1Stock splitJun 12, 1996
- 2-for-1Stock splitJun 10, 1992
- 2-for-1Stock splitMay 11, 1989
- 3-for-1Stock splitMay 19, 1981
- 3-for-1Stock splitMay 18, 1970
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 5.02, 9.01Officer / director changeAug 4, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJul 29, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJul 28, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 15, 2026
EDGAR ↗ - 8-K · Items 5.07, 9.01Shareholder voteApr 28, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsApr 14, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJan 21, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsOct 14, 2025
EDGAR ↗ - 8-K · Items 5.02Officer / director changeSep 9, 2025
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 16, 2025
EDGAR ↗
About JOHNSON & JOHNSON
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersNEW BRUNSWICK, NJ
IncorporatedNJ
SEC CIK0000200406 ↗
Former namesJOHNSON & JOHNSON ET AL